Oystein Fodstad

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Living Beings

Disorders

Procedures

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Bergamaschi Anna; Hjortland Geir Olav; Triulzi Tiziana; Sørlie Therese; Johnsen Hilde; Ree Anne Hansen; Russnes Hege Giercksky; Tronnes Sigurd; Maelandsmo Gunhild M; Fodstad Oystein; Borresen-Dale Anne-Lise; Engebraaten Olav
Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models.
Andersson Y; Engebraaten O; Fodstad Ø
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.
Chowdhury Uttio Roy; Samant Rajeev S; Fodstad Oystein; Shevde Lalita A
Emerging role of nuclear protein 1 (NUPR1) in cancer biology.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Oystein Fodstad (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bergamaschi Anna; Hjortland Geir Olav; Triulzi Tiziana; Sørlie Therese; Johnsen Hilde; Ree Anne Hansen; Russnes Hege Giercksky; Tronnes Sigurd; Maelandsmo Gunhild M; Fodstad Oystein; Borresen-Dale Anne-Lise; Engebraaten Olav
Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models.
Molecular oncology 2009;3(5-6):469-82.
2009: Andersson Y; Engebraaten O; Fodstad Ø
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo.
British journal of cancer 2009;101(8):1307-15.
2009: Chowdhury Uttio Roy; Samant Rajeev S; Fodstad Oystein; Shevde Lalita A
Emerging role of nuclear protein 1 (NUPR1) in cancer biology.
Cancer metastasis reviews 2009;28(1-2):225-32.
2009: Bratland Ase; Boender Piet J; Høifødt Hanne K; Østensen Ingrid H G; Ruijtenbeek Rob; Wang Meng-Yu; Berg Jens P; Lilleby Wolfgang; Fodstad Øystein; Ree Anne Hansen
Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profiling.
Clinical & experimental metastasis 2009;26(5):485-96.
2008: Liu Suhu; Ren Suping; Howell Paul; Fodstad Oystein; Riker Adam I
Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
Pigment cell & melanoma research 2008;21(5):545-58.
2008: Lorico A; Mercapide J; Solodushko V; Alexeyev M; Fodstad O; Rappa G
Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma.
Cancer gene therapy 2008;15(9):605-15.
2008: Clark David W; Mitra Aparna; Fillmore Rebecca A; Jiang Wen G; Samant Rajeev S; Fodstad Oystein; Shevde Lalita A
NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
Current cancer drug targets 2008;8(5):421-30.
2008: Chen Yih-Wen; Tekle Christina; Fodstad Oystein
The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion.
Current cancer drug targets 2008;8(5):404-13.
2008: Brunsvig Paal Fr; Flatmark Kjersti; Aamdal Steinar; Høifødt Hanne; Le Hang; Jakobsen Erling; Sandstad Berit; Fodstad Oystein
Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients.
Lung cancer (Amsterdam, Netherlands) 2008;61(2):170-6.
2008: Rappa Germana; Mercapide Javier; Anzanello Fabio; Prasmickaite Lina; Xi Yaguang; Ju Jingfang; Fodstad Oystein; Lorico Aurelio
Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets.
Experimental cell research 2008;314(10):2110-22.
2008: Nakajima Go; Patino-Garcia Ana; Bruheim Skjalg; Xi Yaguang; San Julian Mikel; Lecanda Fernando; Sierrasesumaga Luis; Müller Christoph; Fodstad Oystein; Ju Jingfang
CDH11 expression is associated with survival in patients with osteosarcoma.
Cancer genomics & proteomics 2008;5(1):37-42.
2008: Xi Yaguang; Riker Adam; Shevde-Samant Lalita; Samant Rajeev; Morris Christopher; Gavin Elaine; Fodstad Oystein; Ju Jingfang
Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts.
Cancer genomics & proteomics 2008;5(1):1-35.
2008: Riker Adam I; Enkemann Steven A; Fodstad Oystein; Liu Suhu; Ren Suping; Morris Christopher; Xi Yaguang; Howell Paul; Metge Brandon; Samant Rajeev S; Shevde Lalita A; Li Wenbin; Eschrich Steven; Daud Adil; Ju Jingfang; Matta Jaime
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.
BMC medical genomics 2008;1():13.
2007: Bauer Natalie N; Chen Yih-Wen; Samant Rajeev S; Shevde Lalita A; Fodstad Oystein
Rac1 activity regulates proliferation of aggressive metastatic melanoma.
Experimental cell research 2007;313(18):3832-9.
2007: Lillehammer Trine; Engesaeter Birgit O; Prasmickaite Lina; Maelandsmo Gunhild M; Fodstad Oystein; Engebraaten Olav
Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.
The journal of gene medicine 2007;9(6):440-51.
2007: Rappa Germana; Anzanello Fabio; Alexeyev Mikhail; Fodstad Oystein; Lorico Aurelio
Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
European journal of haematology 2007;78(5):440-8.
2007: Tveito Siri; Maelandsmo Gunhild M; Hoifodt Hanne K; Rasmussen Heidi; Fodstad Oystein
Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value.
Clinical & experimental metastasis 2007;24(5):317-27.
2006: Xi Yaguang; Nakajima Go; Hamil Tray; Fodstad Oystein; Riker Adam; Ju Jingfang
Association of insulin-like growth factor binding protein-3 expression with melanoma progression.
Molecular cancer therapeutics 2006;5(12):3078-84.
2006: Ree Anne Hansen; Stokke Trond; Bratland Ase; Patzke Sebastian; Nome Ragnhild V; Folkvord Sigurd; Meza-Zepeda Leonardo A; Flatmark Kjersti; Fodstad Oystein; Andersson Yvonne
DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting.
Anticancer research 2006;26(3A):1909-16.
2006: Mbeunkui Flaubert; Fodstad Oystein; Pannell Lewis K
Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS.
Journal of proteome research 2006;5(4):899-906.
2005: Lillehammer Trine; Tveito Siri; Engesaeter Birgit O; Fodstad Oystein; Maelandsmo Gunhild M; Engebraaten Olav
Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
Cancer gene therapy 2005;12(11):864-72.
2005: Nome Ragnhild V; Bratland Ase; Harman Gunhild; Fodstad Oystein; Andersson Yvonne; Ree Anne Hansen
Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death.
Molecular cancer therapeutics 2005;4(8):1231-8.
2005: Bjørnland Kristin; Flatmark Kjersti; Pettersen Solveig; Aaasen Ansgar O; Fodstad Oystein; Maelandsmo Gunhild M
Matrix metalloproteinases participate in osteosarcoma invasion.
The Journal of surgical research 2005;127(2):151-6.
2005: Bruland Oyvind S; Høifødt Hanne; Saeter Gunnar; Smeland Sigbjørn; Fodstad Oystein
Hematogenous micrometastases in osteosarcoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4666-73.
2005: Lorico Aurelio; Bratbak Daniel; Meyer Johann; Kunke David; Krauss Stefan; Plott Walter E; Solodushko Victor; Baum Christopher; Fodstad Oystein; Rappa Germana
Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells.
Human gene therapy 2005;16(6):711-24.
2004: Ree Anne Hansen; Bratland Ase; Nome Ragnhild V; Stokke Trond; Fodstad Oystein; Andersson Yvonne
Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;72(3):305-10.
2004: Ree Anne Hansen; Bratland Ase; Solberg Landsverk Kirsti; Fodstad Oystein
Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner.
Anticancer research 2004;24(2B):555-62.
2004: Hjortland Geir Olav; Garman-Vik Solveig Suzanne; Juell Siri; Olsen Oyvind Edon; Hirschberg Henry; Fodstad Oystein; Engebraaten Olav
Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme.
Journal of neurosurgery 2004;100(2):320-7.
2004: Bruheim Skjalg; Bruland Oyvind S; Breistol Knut; Maelandsmo Gunhild M; Fodstad Oystein
Human osteosarcoma xenografts and their sensitivity to chemotherapy.
Pathology oncology research : POR 2004;10(3):133-41.
2004: King Judy A; Ofori-Acquah Solomon F; Stevens Troy; Al-Mehdi Abu-Bakr; Fodstad Oystein; Jiang Wen G
Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator.
Breast cancer research : BCR 2004;6(5):R478-87.
2004: Rappa G; Kunke D; Holter J; Diep D B; Meyer J; Baum C; Fodstad O; Krauss S; Lorico A
Efficient expansion and gene transduction of mouse neural stem/progenitor cells on recombinant fibronectin.
Neuroscience 2004;124(4):823-30.
2003: Bjørnland Kristin; Flatmark Kjersti; Mala Tom; Mathisen Oystein; Bakka Arne; Aasen Ansgar O; Bergan Anstein; Søreide Odd; Fodstad Oystein
Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer.
Journal of surgical oncology 2003;82(4):224-7.
2003: Rappa G; Gamcsik M P; Mitina R L; Baum C; Fodstad O; Lorico A
Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy.
European journal of cancer (Oxford, England : 1990) 2003;39(1):120-8.
2003: Mathisen Berit; Lindstad Rune I; Hansen Janne; El-Gewely Sara Ann; Maelandsmo Gunhild M; Hovig Eivind; Fodstad Oystein; Loennechen Thrina; Winberg Jan-Olof
S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells.
Clinical & experimental metastasis 2003;20(8):701-11.
2003: Bratland Ase; Ragnhildstveit Erlend; Bjørnland Kristin; Andersen Kristin; Maelandsmo Gunhild Mari; Fodstad Oystein; Saatcioglu Fahri; Ree Anne Hansen
The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells.
Clinical & experimental metastasis 2003;20(6):541-7.
2003: Hjortland G O; Bjørnland K; Pettersen S; Garman-Vik S S; Emilsen E; Nesland J M; Fodstad O; Engebraaten O
Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1.
Clinical & experimental metastasis 2003;20(4):301-9.
2002: Ree Anne Hansen; Bratland Ase; Kroes Roger A; Aasheim Hans-Christian; Flørenes Vivi A; Moskal Joseph R; Fodstad Oystein; Bruland Oyvind S; Maelandsmo Gunhild M
Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases.
Anticancer research 2002;22(4):1949-57.
2002: Høgset Anders; Engesaeter Birgit Ovstebø; Prasmickaite Lina; Berg Kristian; Fodstad Oystein; Maelandsmo Gunhild Mari
Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy.
Cancer gene therapy 2002;9(4):365-71.
2002: Lorico Aurelio; Bertola Antonella; Baum Christopher; Fodstad Oystein; Rappa Germana
Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice.
Biochemical and biophysical research communications 2002;291(3):617-22.
2002: Engebraaten Olav; Hjortland Geir Olav; Juell Siri; Hirschberg Henry; Fodstad Oystein
Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals.
International journal of cancer. Journal international du cancer 2002;97(6):846-52.
2002: Lorico Aurelio; Nesland Jahn; Emilsen Elisabeth; Fodstad Oystein; Rappa Germana
Role of the multidrug resistance protein 1 gene in the carcinogenicity of aflatoxin B1: investigations using mrp1-null mice.
Toxicology 2002;171(2-3):201-5.
2001: Selbo P K; Sivam G; Fodstad O; Sandvig K; Berg K
In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy.
International journal of cancer. Journal international du cancer 2001;92(5):761-6.
2001: Hovig E; Maelandsmo G; Mellingsaeter T; Fodstad O; Mielewczyk S S; Wolfe J; Goodchild J
Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA.
Antisense & nucleic acid drug development 2001;11(2):67-75.
2001: Fodstad O; Faye R; Høifødt H K; Skovlund E; Aamdal S
Immunobead-based detection and characterization of circulating tumor cells in melanoma patients.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2001;158():40-50.
2000: Engebraaten O; Sivam G; Juell S; Fodstad O
Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats.
International journal of cancer. Journal international du cancer 2000;88(6):970-6.
2000: Bratland A; Risberg K; Maelandsmo G M; Gützkow K B; Olsen O E; Moghaddam A; Wang M Y; Hansen C M; Blomhoff H K; Berg J P; Fodstad O; Ree A H
Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells.
Cancer research 2000;60(19):5578-83.
2000: Selbo P K; Sivam G; Fodstad O; Sandvig K; Berg K
Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31-gelonin.
International journal of cancer. Journal international du cancer 2000;87(6):853-9.
2000: Ree A H; Pacheco M M; Tvermyr M; Fodstad O; Brentani M M
Expression of a novel factor, com1, in early tumor progression of breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1778-83.
2000: Rappa G; Shyam K; Lorico A; Fodstad O; Sartorelli A C
Structure-activity studies of novobiocin analogs as modulators of the cytotoxicity of etoposide (VP-16).
Oncology research 2000;12(3):113-9.
1999: Bjørnland K; Winberg J O; Odegaard O T; Hovig E; Loennechen T; Aasen A O; Fodstad O; Maelandsmo G M
S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
Cancer research 1999;59(18):4702-8.
1999: Ree A H; Tvermyr M; Engebraaten O; Rooman M; Røsok O; Hovig E; Meza-Zepeda L A; Bruland O S; Fodstad O
Expression of a novel factor in human breast cancer cells with metastatic potential.
Cancer research 1999;59(18):4675-80.
1999: Breistøl K; Hendriks H R; Fodstad O
Superior therapeutic efficacy of N-L-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drug.
European journal of cancer (Oxford, England : 1990) 1999;35(7):1143-9.
1999: Engebraaten O; Fodstad O
Site-specific experimental metastasis patterns of two human breast cancer cell lines in nude rats.
International journal of cancer. Journal international du cancer 1999;82(2):219-25.
1999: Breistøl K; Balzarini J; Sandvold M L; Myhren F; Martinsen M; De Clercq E; Fodstad O
Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.
Cancer research 1999;59(12):2944-9.
1999: Forus A; Høifødt H K; Overli G E; Myklebost O; Fodstad O
Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates.
Molecular pathology : MP 1999;52(2):68-74.
1999: Berg K; Selbo P K; Prasmickaite L; Tjelle T E; Sandvig K; Moan J; Gaudernack G; Fodstad O; Kjølsrud S; Anholt H; Rodal G H; Rodal S K; Høgset A
Photochemical internalization: a novel technology for delivery of macromolecules into cytosol.
Cancer research 1999;59(6):1180-3.
1999: Engebraaten O; Hjortland G O; Hirschberg H; Fodstad O
Growth of precultured human glioma specimens in nude rat brain.
Journal of neurosurgery 1999;90(1):125-32.
1999: Ruud P; Fodstad O; Hovig E
Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells.
International journal of cancer. Journal international du cancer 1999;80(1):119-25.
1998: Breistøl K; Hendriks H R; Berger D P; Langdon S P; Fiebig H H; Fodstad O
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts.
European journal of cancer (Oxford, England : 1990) 1998;34(10):1602-6.
1998: Andersen K; Maelandsmo G M; Hovig E; Fodstad O; Loennechen T; Winberg J O
Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPL.
Anticancer research 1998;18(5A):3299-303.
1998: Prasmickaite L; Hogset A; Maelandsmo G; Berg K; Goodchild J; Perkins T; Fodstad O; Hovig E
Intracellular metabolism of a 2'-O-methyl-stabilized ribozyme after uptake by DOTAP transfection or asfree ribozyme. A study by capillary electrophoresis.
Nucleic acids research 1998;26(18):4241-8.
1998: Forus A; Berner J M; Meza-Zepeda L A; Saeter G; Mischke D; Fodstad O; Myklebost O
Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas.
British journal of cancer 1998;78(4):495-503.
1998: Ree A H; Bjørnland K; Brünner N; Johansen H T; Pedersen K B; Aasen A O; Fodstad O
Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells.
Clinical & experimental metastasis 1998;16(3):205-15.
1998: Rye P D; Fodstad O; Emilsen E; Bryne M
Invasion potential and N-acetylgalactosamine expression in a human melanoma model.
International journal of cancer. Journal international du cancer 1998;75(4):609-14.
1998: Bjørnland K; Lehne G; Johansen H T; Fodstad O; Rugstad H E; Aasen A O; Ree A H
Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells.
Oncology research 1998;10(5):255-62.
1997: Ree A H; Florenes V A; Berg J P; Maelandsmo G M; Nesland J M; Fodstad O
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1623-8.
1997: Maelandsmo G M; Flørenes V A; Mellingsaeter T; Hovig E; Kerbel R S; Fodstad O
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma.
International journal of cancer. Journal international du cancer 1997;74(4):464-9.
1997: de Graaf H; Maelandsmo G M; Ruud P; Forus A; Oyjord T; Fodstad O; Hovig E
Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2.
International journal of cancer. Journal international du cancer 1997;72(1):191-6.
1997: Berner J M; Meza-Zepeda L A; Kools P F; Forus A; Schoenmakers E F; Van de Ven W J; Fodstad O; Myklebost O
HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas.
Oncogene 1997;14(24):2935-41.
1997: Semb K A; Fodstad O; Klem B; Bibow K; Osmundsen K; Aamdal S
Zilascorb(2H), a new reversible protein synthesis inhibitor: clinical study of an oral preparation.
Anti-cancer drugs 1997;8(3):296-303.
1997: Rye P D; Høifødt H K; Overli G E; Fodstad O
Immunobead filtration: a novel approach for the isolation and propagation of tumor cells.
The American journal of pathology 1997;150(1):99-106.
1996: Maelandsmo G M; Hovig E; Skrede M; Engebraaten O; Flørenes V A; Myklebost O; Grigorian M; Lukanidin E; Scanlon K J; Fodstad O
Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme.
Cancer research 1996;56(23):5490-8.
1996: Maelandsmo G M; Holm R; Fodstad O; Kerbel R S; Flørenes V A
Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions.
The American journal of pathology 1996;149(6):1813-22.
1996: Berner J M; Forus A; Elkahloun A; Meltzer P S; Fodstad O; Myklebost O
Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas.
Genes, chromosomes & cancer 1996;17(4):254-9.
1996: Rye P D; Norum L; Olsen D R; Garman-Vik S; Kaul S; Fodstad O
Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11.
International journal of cancer. Journal international du cancer 1996;68(5):682-7.
1996: Ree A H; Maelandsmo G M; Fodstad O
Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression.
Clinical & experimental metastasis 1996;14(4):381-8.
1996: Kvalheim G; Wang M Y; Pharo A; Holte H; Jacobsen E; Beiske K; Kvaløy S; Smeland E; Funderud S; Fodstad O
Purging of tumor cells from leukapheresis products: experimental and clinical aspects.
Journal of hematotherapy 1996;5(4):427-36.
1996: Bjørnland K; Buø L; Kjønniksen I; Larsen M; Fodstad O; Johansen H T; Aasen A O
Cysteine proteinase inhibitors reduce malignant melanoma cell invasion in vitro.
Anticancer research 1996;16(4A):1627-31.
1996: Maelandsmo G M; Flørenes V A; Hovig E; Oyjord T; Engebraaten O; Holm R; Børresen A L; Fodstad O
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
British journal of cancer 1996;73(8):909-16.
1996: Fodstad O; Breistøl K; Pettit G R; Shoemaker R H; Boyd M R
Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts.
Journal of experimental therapeutics & oncology 1996;1(2):119-25.
1995: Rye P D; Bovin N V; Vlasova E; Høifødt H K; Kierulf B; Trones G E; Fodstad O
Breast cancer-associated antibody LU BCRU G7 recognises the terminal disaccharide Gal beta 1-3GlcNAc and can be used to isolate tumour cells from body fluids by an immunomagnetic bead procedure.
Biochemical Society transactions 1995;23(4):584S.
1995: Forus A; Weghuis D O; Smeets D; Fodstad O; Myklebost O; van Kessel A G
Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas.
Genes, chromosomes & cancer 1995;14(1):8-14.
1995: Forus A; Weghuis D O; Smeets D; Fodstad O; Myklebost O; Geurts van Kessel A
Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas.
Genes, chromosomes & cancer 1995;14(1):15-21.
1995: Maelandsmo G M; Berner J M; Flørenes V A; Forus A; Hovig E; Fodstad O; Myklebost O
Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
British journal of cancer 1995;72(2):393-8.
1995: Wen D Y; Hall W A; Conrad J; Godal A; Flørenes V A; Fodstad O
In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line.
Neurosurgery 1995;36(6):1158-63; discussion 1163-4.
1995: Flørenes V A; Holm R; Fodstad O
Accumulation of p53 protein in human malignant melanoma. Relationship to clinical outcome.
Melanoma research 1995;5(3):183-7.
1995: Helseth A; Haug E; Nesland J M; Siegal G P; Fodstad O; Bautch V L
Endocrine and metabolic characteristics of polyoma large T transgenic mice that develop ACTH-producing pituitary tumors.
Journal of neurosurgery 1995;82(5):879-85.
1995: Deggerdal A H; Pettersen F; Kvalheim G; Hornes E; Smeland E; Fodstad O; Hovig E
Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach.
Laboratory investigation; a journal of technical methods and pathology 1995;72(4):411-8.
1995: Winderen M; Kjønniksen I; Fodstad O
Pronounced therapeutic effect of samarium 153-ethylenediaminetetramethylene phosphonate in an orthotopic human osteosarcoma tibial tumor model.
Journal of the National Cancer Institute 1995;87(3):221-2.
1994: Forus A; Flørenes V A; Maelandsmo G M; Fodstad O; Myklebost O
The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas.
Cancer genetics and cytogenetics 1994;78(2):165-71.
1994: Buø L; Bjørnland K; Karlsrud T S; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen H T; Aasen A O
Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
Anticancer research 1994;14(6B):2445-51.
1994: Flørenes V A; Maelandsmo G M; Forus A; Andreassen A; Myklebost O; Fodstad O
MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
Journal of the National Cancer Institute 1994;86(17):1297-302.
1994: Fodstad O; Kjønniksen I
Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis.
Journal of cellular biochemistry 1994;56(1):23-8.
1994: Kjønniksen I; Rye P D; Fodstad O
Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice.
British journal of cancer 1994;69(6):1021-4.
1994: Langdon S P; Hendriks H R; Braakhuis B J; Pratesi G; Berger D P; Fodstad O; Fiebig H H; Boven E
Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(5):415-22.
1994: Myklebust A T; Godal A; Fodstad O
Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer.
Cancer research 1994;54(8):2146-50.
1994: Kjønniksen I; Winderen M; Bruland O; Fodstad O
Validity and usefulness of human tumor models established by intratibial cell inoculation in nude rats.
Cancer research 1994;54(7):1715-9.
1994: Hall W A; Myklebust A; Godal A; Nesland J M; Fodstad O
In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma.
Neurosurgery 1994;34(4):649-55; discussion 655-6.
1994: Flørenes V A; Oyjord T; Holm R; Skrede M; Børresen A L; Nesland J M; Fodstad O
TP53 allele loss, mutations and expression in malignant melanoma.
British journal of cancer 1994;69(2):253-9.
1994: Flørenes V A; Holm R; Myklebost O; Lendahl U; Fodstad O
Expression of the neuroectodermal intermediate filament nestin in human melanomas.
Cancer research 1994;54(2):354-6.
1994: Myklebust A T; Godal A; Juell S; Pharo A; Fodstad O
Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow.
Cancer research 1994;54(1):209-14.
1994: Bruland O S; Fodstad O; Aas M; Solheim O P; Høie J; Skretting A; Winderen M; Michaelsen T; Pihl A
Immunoscintigraphy of bone sarcomas--results in 5 patients.
European journal of cancer (Oxford, England : 1990) 1994;30A(10):1484-9.
1994: Kvalheim G; Jakobsen E; Holte H; Beiske K; Langholm R; Høiby A; Wang M Y; Funderund S; Fodstad O; Smeland E
Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads.
Progress in clinical and biological research 1994;389():133-8.
1994: Wang M Y; Fodstad O; Funderud S; Bengtsson M; Totterman T; Ludwig W D; Martin H; Kvalheim G
A direct and effective immunomagnetic method for bone marrow purging in non-T ALL malignancies. The use of an anti-HLA-DR antibody gives sustained engraftment.
Progress in clinical and biological research 1994;389():119-24.
1994: Myklebust A T; Helseth A; Breistøl K; Hall W A; Fodstad O
Nude rat models for human tumor metastasis to CNS. Procedures for intracarotid delivery of cancer cells and drugs.
Journal of neuro-oncology 1994;21(3):215-24.
1993: Forus A; Flørenes V A; Maelandsmo G M; Meltzer P S; Fodstad O; Myklebost O
Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(12):1065-70.
1993: Wen D Y; Hall W A; Fodstad O
Rapid detection of transferrin receptor expression on glioma cell lines by using magnetic microspheres.
Neurosurgery 1993;33(5):878-81.
1993: Myklebust A T; Godal A; Pharo A; Juell S; Fodstad O
Eradication of small cell lung cancer cells from human bone marrow with immunotoxins.
Cancer research 1993;53(16):3784-8.
1993: Myklebust A T; Pharo A; Fodstad O
Effective removal of SCLC cells from human bone marrow. Use of four monoclonal antibodies and immunomagnetic beads.
British journal of cancer 1993;67(6):1331-6.
1993: Helseth A; Bautch V L; Haug E; Holm R; Nesland J M; Fodstad O
[Transgenic mice as animal model of Cushing's syndrome]
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1993;113(2):206-10.
1992: Hendriks H R; Plowman J; Berger D P; Paull K D; Fiebig H H; Fodstad O; Dreef-van der Meulen H C; Henrar R E; Pinedo H M; Schwartsmann G
Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agent.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(9):755-63.
1992: Boven E; Winograd B; Berger D P; Dumont M P; Braakhuis B J; Fodstad O; Langdon S; Fiebig H H
Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study.
Cancer research 1992;52(21):5940-7.
1992: Flørenes V A; Aamdal S; Myklebost O; Maelandsmo G M; Bruland O S; Fodstad O
Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.
Cancer research 1992;52(21):6088-91.
1992: Godal A; Kumle B; Pihl A; Juell S; Fodstad O
Immunotoxins directed against the high-molecular-weight melanoma-associated antigen. Identification of potent antibody-toxin combinations.
International journal of cancer. Journal international du cancer 1992;52(4):631-5.
1992: Beiske K; Myklebust A T; Aamdal S; Langholm R; Jakobsen E; Fodstad O
Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods.
The American journal of pathology 1992;141(3):531-8.
1992: Wang M Y; Kvalheim G; Kvaløy S; Beiske K; Jakobsen E; Wijdenes J; Pihl A; Fodstad O
An effective immunomagnetic method for bone marrow purging in T cell malignancies.
Bone marrow transplantation 1992;9(5):319-23.
1992: Hall W A; Godal A; Juell S; Fodstad O
In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme.
Journal of neurosurgery 1992;76(5):838-44.
1992: Kjønniksen I; Breistøl K; Fodstad O
Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatin.
Cancer research 1992;52(5):1347-51.
1992: Hall W A; Fodstad O
Immunotoxins and central nervous system neoplasia.
Journal of neurosurgery 1992;76(1):1-12.
1992: Hendriks H R; Langdon S; Berger D P; Breistøl K; Fiebig H H; Fodstad O; Schwartsmann G
Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):767-73.
1991: Hovig E; Lothe R; Farrants G; Brøgger A; Fodstad O; Børresen A L
Chromosome 13 alterations in osteosarcoma cell lines derived from a patient with previous retinoblastoma.
Cancer genetics and cytogenetics 1991;57(1):31-40.
1991: Kjønniksen I; Høifødt H K; Pihl A; Fodstad O
Different metastasis patterns of a human melanoma cell line in nude mice and rats: influence of microenvironment.
Journal of the National Cancer Institute 1991;83(14):1020-4.
1991: Myklebust A T; Beiske K; Pharo A; Davies C D; Aamdal S; Fodstad O
Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis.
The British journal of cancer. Supplement 1991;14():49-53.
1991: Storeng R T; Kjønniksen I; Pihl A; Haug E; Fodstad O
Athymic rats in preclinical immunodiagnostic studies.
Anticancer research 1991;11(2):649-55.
1990: Kjønniksen I; Nesland J M; Pihl A; Fodstad O
Nude rat model for studying metastasis of human tumor cells to bone and bone marrow.
Journal of the National Cancer Institute 1990;82(5):408-12.
1989: Kvalheim G; Fjeld J G; Pihl A; Funderud S; Ugelstad J; Fodstad O; Nustad K
Immunomagnetic removal of B-lymphoma cells using a novel mono-sized magnetizable polymer bead, M-280, in conjunction with primary IgM and IgG antibodies.
Bone marrow transplantation 1989;4(5):567-74.
1989: Kjønniksen I; Storeng R; Pihl A; McLemore T L; Fodstad O
A human tumor lung metastasis model in athymic nude rats.
Cancer research 1989;49(18):5148-52.
1988: Kvalheim G; Funderud S; Kvaløy S; Gaudernack G; Beiske K; Jakobsen E; Jacobsen A B; Pihl A; Fodstad O
Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantation.
Journal of the National Cancer Institute 1988;80(16):1322-5.
1988: Godal A; Fodstad O; Pihl A
Kinetics of uptake and degradation of an abrin immunotoxin by melanoma cells and studies of the rates of cellular intoxication.
International journal of cancer. Journal international du cancer 1988;42(3):400-4.
1988: Bruland O S; Fodstad O; Stenwig A E; Pihl A
Expression and characteristics of a novel human osteosarcoma-associated cell surface antigen.
Cancer research 1988;48(18):5302-9.
1988: Fodstad O; Kjønniksen I; Aamdal S; Nesland J M; Boyd M R; Pihl A
Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells.
Cancer research 1988;48(15):4382-8.
1988: Fodstad O; Kvalheim G; Pihl A; Godal A; Funderud S
New indirect approach to the therapeutic use of immunotoxins.
Journal of the National Cancer Institute 1988;80(6):439-43.
1988: Fodstad O; Aamdal S; McMenamin M; Nesland J M; Pihl A
A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX.
International journal of cancer. Journal international du cancer 1988;41(3):442-9.
1988: Kvalheim G; Sørensen O; Fodstad O; Funderud S; Kiesel S; Dörken B; Nustad K; Jakobsen E; Ugelstad J; Pihl A
Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use.
Bone marrow transplantation 1988;3(1):31-41.
1988: Aamdal S; Fodstad O; Pihl A
Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumors.
Cancer chemotherapy and pharmacology 1988;21(2):129-33.
1987: Aamdal S; Fodstad O; Pihl A
Some procedures to reduce cis-platinum toxicity reduce antitumour activity.
Cancer treatment reviews 1987;14(3-4):389-95.
1987: Godal A; Fodstad O; Pihl A
Studies on the mechanism of action of abrin-9.2.27 immunotoxin in human melanoma cell lines.
Cancer research 1987;47(23):6243-7.
1987: Kvalheim G; Fodstad O; Pihl A; Nustad K; Pharo A; Ugelstad J; Funderud S
Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
Cancer research 1987;47(3):846-51.
1987: Hovig E; Winberg J O; Fodstad O; Brøgger A; Gedde-Dahl T
Chromosome 13 instability and esterase D expression in an osteosarcoma cell line.
Cancer genetics and cytogenetics 1987;24(2):327-34.
1986: Godal A; Fodstad O; Morgan A C; Pihl A
Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins.
Journal of the National Cancer Institute 1986;77(6):1247-53.
1984: Fodstad O; Kvalheim G; Godal A; Lotsberg J; Aamdal S; Høst H; Pihl A
Phase I study of the plant protein ricin.
Cancer research 1984;44(2):862-5.
1984: Godal A; Fodstad O; Ingebrigtsen K; Pihl A
Pharmacological studies of ricin in mice and humans.
Cancer chemotherapy and pharmacology 1984;13(3):157-63.
1983: Godal A; Fodstad O; Pihl A
Antibody formation against the cytotoxic proteins abrin and ricin in humans and mice.
International journal of cancer. Journal international du cancer 1983;32(4):515-21.
1982: Tveit K M; Fodstad O; Lotsberg J; Vaage S; Pihl A
Colony growth and chemosensitivity in vitro of human melanoma biopsies. Relationship to clinical parameters.
International journal of cancer. Journal international du cancer 1982;29(5):533-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Oystein Fodstad

Research Profile (preview)

Anatomy

Living Beings

Disorders

Procedures

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Oystein Fodstad (preview)

All Publications